calcium-dependent lipopeptide antibiotics (RecombinoGen)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecalcium-dependent lipopeptide antibiotics (RecombinoGen)
Drug Alias Namerumycin 1rumycins (RecombinoGen)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Lipopeptide antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecombinoGen Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecombinoGen Ltd
Active IndicationsN/A
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A